142 related articles for article (PubMed ID: 2840050)
1. alpha 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine.
Heninger GR; Charney DS; Price LH
Arch Gen Psychiatry; 1988 Aug; 45(8):718-26. PubMed ID: 2840050
[TBL] [Abstract][Full Text] [Related]
2. Alpha 2-adrenergic receptor function in depression. The cortisol response to yohimbine.
Price LH; Charney DS; Rubin AL; Heninger GR
Arch Gen Psychiatry; 1986 Sep; 43(9):849-58. PubMed ID: 3019271
[TBL] [Abstract][Full Text] [Related]
3. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.
Charney DS; Heninger GR
Arch Gen Psychiatry; 1985 May; 42(5):473-81. PubMed ID: 2985014
[TBL] [Abstract][Full Text] [Related]
4. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
Charney DS; Heninger GR; Breier A
Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
[TBL] [Abstract][Full Text] [Related]
5. Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine.
Charney DS; Heninger GR; Sternberg DE
Life Sci; 1982 Jun; 30(23):2033-41. PubMed ID: 6287139
[TBL] [Abstract][Full Text] [Related]
6. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
Charney DS; Woods SW; Goodman WK; Heninger GR
Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
[TBL] [Abstract][Full Text] [Related]
7. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.
Charney DS; Heninger GR
Arch Gen Psychiatry; 1986 Nov; 43(11):1042-54. PubMed ID: 3021083
[TBL] [Abstract][Full Text] [Related]
8. Effects of yohimbine in obsessive compulsive disorder.
Rasmussen SA; Goodman WK; Woods SW; Heninger GR; Charney DS
Psychopharmacology (Berl); 1987; 93(3):308-13. PubMed ID: 2829264
[TBL] [Abstract][Full Text] [Related]
9. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.
McDougle CJ; Krystal JH; Price LH; Heninger GR; Charney DS
Psychopharmacology (Berl); 1995 Mar; 118(2):127-35. PubMed ID: 7617798
[TBL] [Abstract][Full Text] [Related]
10. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects.
Siever LJ; Uhde TW; Jimerson DC; Lake CR; Silberman ER; Post RM; Murphy DL
Am J Psychiatry; 1984 Jun; 141(6):733-41. PubMed ID: 6329004
[TBL] [Abstract][Full Text] [Related]
12. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
Charney DS; Heninger GR
Arch Gen Psychiatry; 1985 May; 42(5):458-67. PubMed ID: 2859008
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment.
Charney DS; Heninger GR; Sternberg DE; Redmond DE; Leckman JF; Maas JW; Roth RH
Arch Gen Psychiatry; 1981 Dec; 38(12):1334-40. PubMed ID: 6274268
[TBL] [Abstract][Full Text] [Related]
14. Noradrenergic function in schizophrenia.
Glazer WM; Charney DS; Heninger GR
Arch Gen Psychiatry; 1987 Oct; 44(10):898-904. PubMed ID: 3662745
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
[TBL] [Abstract][Full Text] [Related]
16. Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder.
Charney DS; Woods SW; Heninger GR
Psychiatry Res; 1989 Feb; 27(2):173-82. PubMed ID: 2540501
[TBL] [Abstract][Full Text] [Related]
17. Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls.
Gurguis GN; Uhde TW
Psychoneuroendocrinology; 1990; 15(3):217-24. PubMed ID: 2255749
[TBL] [Abstract][Full Text] [Related]
18. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD.
Rasmusson AM; Hauger RL; Morgan CA; Bremner JD; Charney DS; Southwick SM
Biol Psychiatry; 2000 Mar; 47(6):526-39. PubMed ID: 10715359
[TBL] [Abstract][Full Text] [Related]
19. Noradrenergic responses to clonidine in acute and remitted depressed male patients.
Trestman RL; Lawrence TL; Coccaro EF; Harvey P; Bernstein D; Lawrence EK; Condello V; Mahon T; Yang RK; Knott P
Psychiatry Res; 1992 Sep; 43(3):199-213. PubMed ID: 1332095
[TBL] [Abstract][Full Text] [Related]
20. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine.
Siever LJ; Uhde TW
Biol Psychiatry; 1984 Feb; 19(2):131-56. PubMed ID: 6324896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]